These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 23424758

  • 1. From the target pressure to the individual normalocular pressure, a step forward in the glaucoma treatment.
    Potop V.
    Oftalmologia; 2012; 56(2):21-4. PubMed ID: 23424758
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z, EMGT Group.
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [Abstract] [Full Text] [Related]

  • 4. Early aggressive intraocular pressure lowering, target intraocular pressure, and a novel concept for glaucoma care.
    Singh K, Shrivastava A.
    Surv Ophthalmol; 2008 Nov; 53 Suppl1():S33-8. PubMed ID: 19038622
    [Abstract] [Full Text] [Related]

  • 5. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A, Sánchez M.
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [Abstract] [Full Text] [Related]

  • 6. Glaucoma case report: a nutritional response.
    Veach JE.
    Optometry; 2003 Dec; 74(12):775-81. PubMed ID: 14677729
    [Abstract] [Full Text] [Related]

  • 7. [Up-to-date management of glaucoma].
    Holló G.
    Orv Hetil; 2004 Jun 20; 145(25):1337-9. PubMed ID: 15285153
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Investigation of the biomechanical properties of the cornea in patients with normotensive and primary open-angle glaucoma].
    Avetisov SE, Bubnova IA, Antonov AA.
    Vestn Oftalmol; 2008 Jun 20; 124(5):14-6. PubMed ID: 19062550
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.
    Heijl A, Leske MC, Hyman L, Yang Z, Bengtsson B, EMGT Group.
    Acta Ophthalmol; 2011 Dec 20; 89(8):749-54. PubMed ID: 20236252
    [Abstract] [Full Text] [Related]

  • 12. [Cornea between constant and parameter in glaucoma diagnosis and treatment].
    Potop V.
    Oftalmologia; 2013 Dec 20; 57(3):3-8. PubMed ID: 24701808
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Focusing on glaucoma progression and the clinical importance of progression rate measurement: a review.
    Rossetti L, Goni F, Denis P, Bengtsson B, Martinez A, Heijl A.
    Eye (Lond); 2010 Oct 20; 24 Suppl 1():S1-7. PubMed ID: 20944656
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intraocular pressure lowering efficacy and safety of travoprost 0.004% as a replacement therapy in patients with open angle glaucoma or ocular hypertension.
    Ge J, Sun XH, Wang NL, Zhao JL, Wu LL, Chen XM, Wang ZX, Li B.
    Chin Med J (Engl); 2010 Jun 20; 123(11):1417-21. PubMed ID: 20819599
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.